Endocardial Pulsed Field Ablation and the Oesophagus: Are Atrio-oesophageal Fistulas Now History?

Pulsed field ablation (PFA) is a novel energy form for the catheter ablation of cardiac arrhythmias, which uses electrical fields to mediate myocardial death via irreversible electroporation and other modalities. It is believed to offer relative tissue specificity, lowering - or even eliminating - t...

Full description

Saved in:
Bibliographic Details
Published in:Arrhythmia & electrophysiology review Vol. 13; p. e02
Main Authors: Nies, Moritz, Watanabe, Keita, Kawamura, Iwanari, Koruth, Jacob S
Format: Journal Article
Language:English
Published: England Radcliffe Cardiology 2024
Radcliffe Medical Media
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Pulsed field ablation (PFA) is a novel energy form for the catheter ablation of cardiac arrhythmias, which uses electrical fields to mediate myocardial death via irreversible electroporation and other modalities. It is believed to offer relative tissue specificity, lowering - or even eliminating - the risk of complications associated with thermal energy, such as atrio-oesophageal fistulas. The proposed superior safety profile compared to thermal ablation has contributed to the enthusiastic implementation of PFA into clinical practice and is supported by early preclinical and clinical data. However, data about the effects of PFA on the oesophagus remain limited. This organ's susceptibility to PFA has important clinical ramifications and there are two highly relevant questions. First, is the oesophagus absolutely spared by PFA or is there susceptibility to injury at higher field strengths? Second, if oesophageal injury can occur, can atrio-oesophageal fistulas ensue? The aim of this article is to provide a literature review on the effects of PFA on the oesophagus and to address these questions based on the data described.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Disclosure: MN has received a scholarship from the German Research Foundation (Deutsche Forschungsgemeinschaft). JSK has received consultancy fees from Abbott, Biosense Webster, Boston Scientific, Cardiofocus and Medtronic, research grants from Affera, Cardiofocus and Pulse Bioscience and stock options from Affera. All other authors have no conflicts of interest to declare.
ISSN:2050-3369
2050-3377
DOI:10.15420/aer.2023.16